Obiettivo
Driven by clinical applications and MNT and IST technology, SmartHEALTH will develop an open integrated architecture for new biodiagnostic systems to support European companies exploiting bioassays or new application concepts. Initial system has a disposable fluidic cartridge with a desktop basestation linking to the ambient eHealth environment - health cards, patient data, online services. This concept will be miniaturised and cost engineered into a portable and consumer product. It will perform multianalyate sensing and interpretation, for nucleic acids, proteins and others and will handle multiple biological sample types.
Results will be interpreted and presented using bioinformatics. Systems will be healthcare user identity and ambient environment aware, respecting confidentiality and information access rights. The IP will enable enhanced medical diagnosis, leading to earlier and more precise results contributing to an increased quality of life as well as increasing the competitiveness of the European IVD sector. The IP will include: selection of probes, sample preparation, fluid handling, concentration, filtering; sensors and transducers, (label free systems and rapid nucleic acid detection systems); surface modification/integration of nanoscale elements; system development - controllers, actuators, data processing, communications and integration with ambient intelligence, on-line information services; understanding of fit to healthcare, input to medical management - user factors, costs, approvals, regulations, ethics.
Clinical areas are in Cancer Diagnostics - breast cancer recurrence monitoring, cervical cancer case finding, colorectal cancer - diagnostic/theranostic/prognostics. Each application includes clinical validation and commercial exploitation partners. The consortium is a powerful set of 3 Universities, 9 Research Institutions, 10 SMEs, 4 larger Companies and 4 Clinical Groups covering all the relevant issues.
Campo scientifico
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- social scienceseconomics and businessbusiness and managementcommercee-commerce
- medical and health sciencesclinical medicineoncologybreast cancer
- medical and health sciencesclinical medicineoncologycolorectal cancer
- medical and health sciencesclinical medicineoncologycervical cancer
Parole chiave
Invito a presentare proposte
Data not availableMeccanismo di finanziamento
IP - Integrated ProjectCoordinatore
NE1 7RU NEWCASTLE UPON TYNE
Regno Unito
Mostra sulla mappa
Partecipanti (30)
2007 NEUCHATEL
Mostra sulla mappa
10117 BERLIN
Mostra sulla mappa
GLASNEVIN, DUBLIN 9
Mostra sulla mappa
76133 KARLSRUHE
Mostra sulla mappa
80686 MUENCHEN
Mostra sulla mappa
07743 JENA
Mostra sulla mappa
41455 GOTEBORG
Mostra sulla mappa
48170 ZAMUDIO
Mostra sulla mappa
48150 SONDIKA
Mostra sulla mappa
48903 CRUCES/BARAKALDO
Mostra sulla mappa
20014 DONOSTIA - SAN SEBASTIAN
Mostra sulla mappa
20500 ARRASATE - MONDRAGON
Mostra sulla mappa
55129 MAINZ
Mostra sulla mappa
3001 LEUVEN
Mostra sulla mappa
TW1 4JX TWICKENHAM MIDDLESEX
Mostra sulla mappa
07745 JENA
Mostra sulla mappa
3179 SCORESBY, VICTORIA
Mostra sulla mappa
414 58 GOTEBORG
Mostra sulla mappa
2628 VK DELFT
Mostra sulla mappa
11020 ARNAD
Mostra sulla mappa
01006 VITORIA - GASTEIZ
Mostra sulla mappa
7465 TRONDHEIM
Mostra sulla mappa
413 46 GOTEBORG
Mostra sulla mappa
20123 MILANO
Mostra sulla mappa
2007 NEUCHATEL
Mostra sulla mappa
UNDEFINED
Mostra sulla mappa
43003 TARRAGONA
Mostra sulla mappa
80331 MUENCHEN
Mostra sulla mappa
SN2 2QW SWINDON, WILTSHIRESWINDON WILTSHIRE
Mostra sulla mappa